Abpro Holdings, Inc. (ABPO) stock
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Abpro ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Abpro's ebitda for the twelve months ending Jun 30, 2026 was -$5.33M. For fiscal 2025 it was -$8.43M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.43M | – |
| FY2024 | Dec 31, 2024 | -$9.85M | – |
| FY2023 | Dec 31, 2023 | -$11.47M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.17M | – |
| Q1 FY2026 | Mar 31, 2026 | -$930.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.89M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.33M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.95M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.83M | – |
See a number that looks wrong?